| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.076 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |